KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Liabilities and Shareholders Equity (2017 - 2025)

Historic Liabilities and Shareholders Equity for Guardant Health (GH) over the last 9 years, with Q3 2025 value amounting to $1.3 billion.

  • Guardant Health's Liabilities and Shareholders Equity fell 1702.32% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 billion, marking a year-over-year decrease of 1808.18%. This contributed to the annual value of $1.5 billion for FY2024, which is 1683.88% down from last year.
  • Per Guardant Health's latest filing, its Liabilities and Shareholders Equity stood at $1.3 billion for Q3 2025, which was down 1702.32% from $1.3 billion recorded in Q2 2025.
  • Over the past 5 years, Guardant Health's Liabilities and Shareholders Equity peaked at $2.3 billion during Q1 2021, and registered a low of $1.3 billion during Q3 2025.
  • Its 5-year average for Liabilities and Shareholders Equity is $1.8 billion, with a median of $1.7 billion in 2024.
  • Per our database at Business Quant, Guardant Health's Liabilities and Shareholders Equity surged by 14750.29% in 2021 and then plummeted by 2901.8% in 2023.
  • Over the past 5 years, Guardant Health's Liabilities and Shareholders Equity (Quarter) stood at $2.2 billion in 2021, then fell by 26.97% to $1.6 billion in 2022, then grew by 10.96% to $1.8 billion in 2023, then decreased by 16.84% to $1.5 billion in 2024, then fell by 14.06% to $1.3 billion in 2025.
  • Its last three reported values are $1.3 billion in Q3 2025, $1.3 billion for Q2 2025, and $1.3 billion during Q1 2025.